No abstract available
MeSH terms
-
Aclarubicin
-
Animals
-
Antibiotics, Antineoplastic / adverse effects
-
Antibiotics, Antineoplastic / metabolism
-
Antibiotics, Antineoplastic / pharmacology
-
Antibiotics, Antineoplastic / therapeutic use*
-
Breast Neoplasms / drug therapy
-
Carubicin / therapeutic use
-
Daunorubicin / analogs & derivatives
-
Daunorubicin / therapeutic use
-
Doxorubicin / analogs & derivatives
-
Doxorubicin / therapeutic use
-
Female
-
Glycosides / adverse effects
-
Glycosides / metabolism
-
Glycosides / pharmacology
-
Glycosides / therapeutic use
-
Hodgkin Disease / drug therapy
-
Humans
-
Leukemia / drug therapy
-
Lung Neoplasms / drug therapy
-
Lymphoma / drug therapy
-
Naphthacenes / adverse effects
-
Naphthacenes / metabolism
-
Naphthacenes / pharmacology
-
Naphthacenes / therapeutic use*
-
Ovarian Neoplasms / drug therapy
-
Sarcoma / drug therapy
Substances
-
Antibiotics, Antineoplastic
-
Glycosides
-
Naphthacenes
-
valrubicin
-
Aclarubicin
-
Doxorubicin
-
Carubicin
-
zorubicin
-
Daunorubicin